For GJB2, GBM patients with high outlier expression had the worst prognosis, while for SCN9A, GBM patients with above-median gene expression associated with poor prognosis (Fig. 3B; Appendix Fig. S4a). This evidence concerns the gene SCN9A and glioblastoma.